What are the implications of childhood trauma for depression and its response to therapy?

Childhood trauma is an important risk factor for major depressive disorder (MDD).1 It is significantly more common in people with MDD than in healthy controls,1 and is associated with a greater risk of early onset, recurrence and a more chronic course of MDD,2 and a poor response to standard antidepressant therapy.1

Many people with MDD have experienced childhood trauma

Associated with a more chronic course of MDD

The many types of childhood trauma (or adverse childhood experience [ACE]) include emotional, sexual and physical interpersonal abuse; family separation, breakup or conflict; and experiences of natural disaster.1,2

Among 1008 participants in the international Study to Predict Optimized Treatment for Depression (iSPOT-D), 62.5% reported at least two childhood traumatic events compared with 28.4% of 336 healthy controls (p<0.01).1

 

Negative effects on mental, psychosocial and physical health

An adverse effect on cognitive and brain development

Childhood trauma has a detrimental effect on cognitive development associated with lower IQ, complex visual attention, verbal memory, learning, planning, problem solving, processing speed, language, reading and mathematics scores.3

Having had at least one ACE is significantly associated (p<0.0001) with risk-taking behaviors in adolescents (cigarette smoking, alcohol use, street drug use, at least one suicide attempt) compared with individuals with no ACE.2

More ACEs are also associated with a higher rate of serious family, job and financial problems, and a higher rate of stress, substance abuse and MDD in adult life.2,4

Adverse effects on physical health include a shorter telomere length in children at 5 and 10 years of age,5 general low-grade inflammation in adulthood with higher levels of inflammatory biomarkers,6 a higher blood pressure7 and a higher prevalence of obesity.7

 

A poor response to standard antidepressants

Less likely to respond to SSRI or SNRI

The more chronic course of MDD experienced by people with a history of childhood trauma is compounded by its poor response to standard antidepressant therapy.1

Patients with MDD experiencing childhood trauma between 4 and 7 years of age are 1.6 times less likely to achieve response or remission at 8 weeks when treated with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs).1 Among 722 participants in iSPOT-D:

  • the response rate was only 17.7% compared with 82.3% for patients with no history of childhood abuse
  • the remission rate was only 15.9% compared with 84.1% for patients with no history of childhood abuse1

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Williams LM, et al. Transl Psychiatry 2016;6:e799.
  2. Hillis SD, et al. Pediatrics 2004;113:320–7.
  3. De Bellis MD, et al. Child Adolesc Psychiatr Clin N Am 2014;23(2):185–222.
  4. Got Your ACE Score? https://acestoohigh.com/got-your-ace-score/ Accessed 14 May 2020.
  5. Shalev I, et al. Mol Psychiatry 2013;18:576–81.
  6. Danese A, et al. PNAS 2007;104:1319–24.
  7. McIntyre RS, et al. Int J Psychiatry Med 2012;43:165–77.
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country